# HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer

> **NCT04264208** · PHASE2 · TERMINATED · sponsor: **Andrei Iagaru** · enrollment: 4 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 68-Ga RM2.
- **DRUG:** 68-Ga PSMA11
- **DEVICE:** PET/MRI

## Key facts

- **NCT ID:** NCT04264208
- **Lead sponsor:** Andrei Iagaru
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-05
- **Primary completion:** 2022-11-22
- **Final completion:** 2022-12-14
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Lack of accrual due to pandemic and logistics
- **Last updated:** 2024-02-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04264208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04264208, "HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04264208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*